Since the early 1990s, when Roberts and Szabos cytoprotection concept had already been more than one decade old, but still not implemented in therapy, we suggest the stable gastric pentadecapeptide BPC 157 as the most relevant mediator of the cytoprotection concept.
In this comprehensive guide, we will explore the intricate biochemistry of L-Carnitine Fumarate, how chronic illness disrupts cellular energy, and how this specific formulation may help restore vitality and cardiovascular stability for those navigating the complexities of Long COVID, ME/CFS, and dysautonomia
About this article Cite this article Buhrman, J.S., Rayahin, J.E., Kllmer, M
Austin: Landes Bioscience, 1997: 21531 Murakami K, Sugimoto T, Woo M, et al